Recombinant Human SLAM Family Member 7/SLAMF7/CD319/CRACC (C-mFc)

CAT:
763-PKSH033992-01
Size:
10 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Recombinant Human SLAM Family Member 7/SLAMF7/CD319/CRACC (C-mFc) - image 1

Recombinant Human SLAM Family Member 7/SLAMF7/CD319/CRACC (C-mFc)

  • Background:

    SLAMF7 is a single-pass type I membrane protein and contains 1 Ig-like C2-type (immunoglobulin-like) domain. SLAMF7 is expressed in NK cells, activated B-cells, NK-cell line but not in promyelocytic, B-cell lines, or T-cell lines. Although the cytoplasmic domain of CS1 contains immunoreceptor tyrosine-based switch motifs (ITSM), which enables to recruite signaling lymphocyte activation molecule (SLAM) -associated protein (SAP/SH2D1A), it activates NK cells in the absence of a functional SAP. SLAMF7 positively regulated natural killer cell functions by a mechanism dependent on the adaptor EAT-2 but not the related adaptor SAP. However, in the absence of EAT-2, CRACC potently inhibited natural killer cell function. It was also inhibitory in T cells, which are typically devoid of EAT-2. Thus, SLAMF7 can exert activating or inhibitory influences on cells of the immune system depending on cellular context and the availability of effector proteins.
  • Abbreviation:

    SLAMF7, CD319, CRACC
  • Synonyms:

    UNQ; PRO; SLAM; SLAMF7;19A; CD319; CRACC; CS1;19A24 protein; CD 319; CD2 like receptor activating cytotoxic cells; CD2 subset 1; CD2-Like Receptor-Activating Cytotoxic Cells; CD319 antigen; Membrane protein FOAP 12; Membrane Protein FOAP-12; Novel Ly9; Novel LY9 (lymphocyte antigen 9) like protein; Protein 19A; SLAM family member 7; SLAM7; SLAMF 7; UNQ576; PRO1138; CS1; CD319; CRACC; CS1; Novel Ly9
  • UniProt:

    Q9NQ25
  • Accession Number:

    Q9NQ25
  • Expression System:

    HEK293 Cells
  • Tag:

    C-mFc
  • Sequence:

    Ser23-Met226
  • Field of Research:

    Immunology
  • Endotoxin:

    < 1.0 EU per μg of the protein as determined by the LAL method.
  • Purity:

    > 95 % as determined by reducing SDS-PAGE.
  • Bioactivity:

    Not validated for activity
  • Reconstitution:

    Please refer to the printed manual for detailed information.
  • Shipping Conditions:

    This product is provided as lyophilized powder which is shipped with ice packs.
  • Storage Conditions:

    Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
  • Calculated Molecular Weight:

    49.0 kDa
  • Observed Molecular Weight:

    60 - 90 kDa
  • Formulation:

    Lyophilized from a 0.2 µm filtered solution of PBS, pH 7.4.
    Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
    Please refer to the specific buffer information in the printed manual.
  • Species:

    Human